Thalidomide as a treatment for inflammatory bowel disease in children and adolescents: A systematic review
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.13196
Abstract: Thalidomide is used off‐label for the treatment of inflammatory bowel disease (IBD) and not as a first‐line treatment option. The instructions clearly state that thalidomide is contraindicated in children because its safety and effectiveness in… read more here.
Keywords: bowel disease; treatment inflammatory; inflammatory bowel; treatment ... See more keywords